# Sun Pharma Advanced Research Company Ltd (SPARC)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹180.33
Day Change: -1.82%
52W High: ₹204.4
52W Low: ₹108
Market Cap: ₹5,265 Cr

## Valuation
P/E: 0
P/B: -15.26
EPS: ₹-8.25
Book Value: ₹0
Dividend Yield: 0%

## Returns
1Y Return: 21.84%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: -43.3%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: -700.71%

## About
Sun Pharma Advanced Research Company Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Sun Pharma Advanced Research Company Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Resignation of Director
- Announcement: Announcement under Regulation 30 (LODR)-Meeting Updates
- BSE Filing: Announcement under Regulation 30 (LODR)-Resignation of Director

## Data Freshness
Quote Updated: 2026-05-21T20:00:05.656Z
Price History Updated: 2026-05-18T22:58:36.511Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:36.511Z
Quant Updated: 2026-05-18T22:58:36.511Z
Sentiment Updated: 2026-05-18T22:58:36.511Z
Financials Status: current
Financials Updated: 2026-05-18T12:32:12.175Z
Financials Last Attempt: 2026-05-18T12:32:12.175Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2024)
Revenue: ₹239 Cr
Operating Profit: ₹-214 Cr (OPM -90%)
Net Profit: ₹-223 Cr
Tax: ₹-223 Cr

## Annual P&L History
Mar 2024: Rev ₹239Cr | PAT ₹-223Cr | OPM -90%
Mar 2025: Rev ₹76Cr | PAT ₹-387Cr | OPM -532%
TTM: Rev ₹72Cr | PAT ₹-343Cr | OPM -450%

## Balance Sheet (Mar 2024)
Total Assets: ₹830 Cr
Total Liabilities: ₹830 Cr
Borrowings: ₹16 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Anilkumar  Raghavan, Chief Executive Officer
- Anup  Rathi, Chief Financial Officer
- Nitin  Dharmadhikari, Chief Operating Officer
- Jaydeep  Issrani, Senior General Manager of Business Development, Corporate Communication & Investor Relations
- Kajal K. Damania, Company Secretary & Compliance Officer

---
Source: rupiya.io/stocks/sparc
Disclaimer: For research and education only. Not investment advice.